EyePoint sees stock surge on AMD drug trial data
Shares in EyePoint Pharmaceuticals more than tripled Monday morning after the Massachusetts-based biotechnology company announced summary results from a mid-stage
July 1, 2024
Shares in EyePoint Pharmaceuticals more than tripled Monday morning after the Massachusetts-based biotechnology company announced summary results from a mid-stage
Dive Brief: The Food and Drug Administration granted conditional approval to Eli Lilly’s oral cancer drug Jaypirca in two types
With clinical trials becoming more complex, finding ways to streamline and automate laboratory processes is vital when analyzing bioanalytical samples.
Dive Brief: A contract research organization working for biotechnology company Acelyrin is disputing suggestions that it may be responsible for
AbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion deal to acquire ImmunoGen, a pioneer
Dive Brief: Concentra Biosciences has made an unsolicited bid to acquire all outstanding shares of LianBio, a biotechnology company focused
Europe’s drug regulator has more questions about the safety and potential risks of a new, widely popular class of medicines.
Dive Brief: Pfizer will not advance a twice-daily dose of an experimental obesity drug into further testing after results from
Flagship Pioneering is looking to raise $3 billion for its eighth venture fund, a sign the high-profile company creator continues